<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01518868</url>
  </required_header>
  <id_info>
    <org_study_id>743E</org_study_id>
    <nct_id>NCT01518868</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens</brief_title>
  <official_title>A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the product performance of the investigational&#xD;
      multifocal high add soft contact lens compared with PureVision Multi-focal contact lens on a&#xD;
      daily wear basis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>At 2 weeks follow up</time_frame>
    <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms/Complaints</measure>
    <time_frame>At 2 weeks follow up</time_frame>
    <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Investigational contact lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>multifocal high add soft contact lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PureVision contact lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Multi-focal contact lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational contact lens</intervention_name>
    <description>Worn on a daily wear basis for one week.</description>
    <arm_group_label>Investigational contact lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PureVision contact lens</intervention_name>
    <description>Worn on a daily wear basis for one week</description>
    <arm_group_label>PureVision contact lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have physiologically normal anterior segments&#xD;
&#xD;
          -  Be adapted wearers of soft contact lenses and wear a lens in each eye.&#xD;
&#xD;
          -  Be presbyopic and require near add correction in each eye.&#xD;
&#xD;
          -  Be an adapted monovision or multifocal contact lens wearer or be an adapted spherical&#xD;
             lens wearer who also uses spectacles for near vision correction.&#xD;
&#xD;
          -  Have no active ocular disease or allergic conjunctivitis.&#xD;
&#xD;
          -  Must not be using any topical ocular medications.&#xD;
&#xD;
          -  Must habitually use a lens care product for lens cleaning, disinfecting, and storage.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any Grade 2 or greater finding during the slit lamp examination that, in the&#xD;
             Investigator's judgment, interferes with contact lens wear.&#xD;
&#xD;
          -  Any &quot;Present&quot; finding during the slit lamp examination that, in the Investigator's&#xD;
             judgment, interferes with contact lens wear.&#xD;
&#xD;
          -  Anisometropia (spherical equivalent) of greater than 2.00 D.&#xD;
&#xD;
          -  Any systemic disease affecting ocular health.&#xD;
&#xD;
          -  Using any systemic or topical medications that will affect ocular physiology or lens&#xD;
             performance.&#xD;
&#xD;
          -  Allergic to any component in the study products.&#xD;
&#xD;
          -  Ocular astigmatism of greater than 1.00 D in either eye.&#xD;
&#xD;
          -  Have had any corneal surgery (ie, refractive surgery).&#xD;
&#xD;
          -  Uses AMO Ultra Care as their habitual lens care regimen.&#xD;
&#xD;
          -  Is a toric contact lens wearer.&#xD;
&#xD;
          -  Have worn gas permeable (GP) contact lenses within last 30 days or PMMA lenses within&#xD;
             last 3 months.&#xD;
&#xD;
          -  An active ocular disease (for example but not limited to papillary conjunctivitis, any&#xD;
             conjunctivitis: viral, bacterial, allergic), any corneal infiltrative response or are&#xD;
             using any ocular medications.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beverly J Barna, CCRA</last_name>
    <role>Study Director</role>
    <affiliation>Bausch &amp; Lomb Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bausch &amp; Lomb, Incorporated</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>January 24, 2012</study_first_submitted>
  <study_first_submitted_qc>January 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2012</study_first_posted>
  <results_first_submitted>August 21, 2020</results_first_submitted>
  <results_first_submitted_qc>September 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 30, 2020</results_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 126 participants (252 eyes) were enrolled. One-half of the participants were randomized to receive the investigational contact lens during the first crossover period, and the other half were randomized to receive the PureVision contact lens during the first crossover period. The participants crossed over to the other group at 1 week.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Investigational Contact Lens Then PureVision Contact Lens</title>
          <description>multifocal high add soft contact lens&#xD;
Investigational contact lens: Worn on a daily wear basis for one week.&#xD;
Multi-focal contact lens PureVision contact lens: Worn on a daily wear basis for one week</description>
        </group>
        <group group_id="P2">
          <title>PureVision Contact Lens</title>
          <description>Multi-focal contact lens then Investigational Contact Lens&#xD;
PureVision contact lens: Worn on a daily wear basis for one week&#xD;
multifocal high add soft contact lens Investigational contact lens: Worn on a daily wear basis for one week.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Demography was collected for 124 eligible, dispensed participants. Participants received both treatment groups in this cross-over study.</population>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>Participants received both treatment groups in this cross-over study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="124"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.6" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="106"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
        <time_frame>At 2 weeks follow up</time_frame>
        <population>There were 238 eyes assessed for visual acuity for this outcome measure. Participants/eyes received both treatment groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Contact Lens</title>
            <description>multifocal high add soft contact lens&#xD;
Investigational contact lens: Worn on a daily wear basis for one week.</description>
          </group>
          <group group_id="O2">
            <title>PureVision Contact Lens</title>
            <description>Multi-focal contact lens&#xD;
PureVision contact lens: Worn on a daily wear basis for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).</description>
          <population>There were 238 eyes assessed for visual acuity for this outcome measure. Participants/eyes received both treatment groups.</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eye</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eye</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="238"/>
                <count group_id="O2" value="238"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.079" spread="0.102"/>
                    <measurement group_id="O2" value="0.090" spread="0.091"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptoms/Complaints</title>
        <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
        <time_frame>At 2 weeks follow up</time_frame>
        <population>There were 238 eyes assessed for symptoms/complaints for this outcome measure. Participants/eyes received both treatment groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational Contact Lens</title>
            <description>multifocal high add soft contact lens&#xD;
Investigational contact lens: Worn on a daily wear basis for one week.</description>
          </group>
          <group group_id="O2">
            <title>PureVision Contact Lens</title>
            <description>Multi-focal contact lens&#xD;
PureVision contact lens: Worn on a daily wear basis for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Symptoms/Complaints</title>
          <description>Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.</description>
          <population>There were 238 eyes assessed for symptoms/complaints for this outcome measure. Participants/eyes received both treatment groups.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="119"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="238"/>
                <count group_id="O2" value="238"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Burning/stinging upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.6" spread="8.9"/>
                    <measurement group_id="O2" value="92.5" spread="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort upon insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.4" spread="17.0"/>
                    <measurement group_id="O2" value="81.5" spread="25.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfort at end of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.3" spread="25.4"/>
                    <measurement group_id="O2" value="64.9" spread="28.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.6" spread="20.3"/>
                    <measurement group_id="O2" value="70.5" spread="26.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.3" spread="20.3"/>
                    <measurement group_id="O2" value="73.3" spread="26.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itchiness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.9" spread="13.8"/>
                    <measurement group_id="O2" value="86.8" spread="22.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.4" spread="14.4"/>
                    <measurement group_id="O2" value="86.9" spread="23.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Distance vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.7" spread="29.8"/>
                    <measurement group_id="O2" value="59.3" spread="30.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision at intermediate distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.5" spread="22.5"/>
                    <measurement group_id="O2" value="70.3" spread="25.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vision at near distance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.0" spread="30.0"/>
                    <measurement group_id="O2" value="58.8" spread="30.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" spread="25.4"/>
                    <measurement group_id="O2" value="56.2" spread="27.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.5" spread="20.4"/>
                    <measurement group_id="O2" value="84.3" spread="21.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ease of handling/removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.6" spread="16.3"/>
                    <measurement group_id="O2" value="86.2" spread="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall impression</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.3" spread="23.5"/>
                    <measurement group_id="O2" value="61.1" spread="29.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 weeks</time_frame>
      <desc>Adverse events (AEs) were not coded. Therefore, source vocabulary is not applicable. A total of 126 participants (262 eyes) were assessed for AEs. Participants/eyes received both treatment groups in this cross-over study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Investigational Contact Lens</title>
          <description>multifocal high add soft contact lens&#xD;
Investigational contact lens: Worn on a daily wear basis by adapted monovision soft contact lens wearers for one week.&#xD;
Investigational contact lens: Worn on a daily wear basis by adapted multifocal soft contact wearers for one week.&#xD;
Investigational contact lens: Worn on a daily wear basis by adapted spherical soft contact lens wearers who may also use spectacles for near vision correction for one week</description>
        </group>
        <group group_id="E2">
          <title>PureVision Contact Lens</title>
          <description>Multi-focal contact lens&#xD;
PureVision contact lens: Worn on a daily wear basis by adapted monovision soft contact lens wearers for one week&#xD;
PureVision contact lens: Worn on a daily wear basis by adapted multifocal soft contact wearers for one week.&#xD;
PureVision contact lens: Worn on a daily wear basis by adapted spherical soft contact lens wearers who may also use spectacles for near vision correction for one week</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="126"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Contact sponsor directly for details.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Bausch Health</organization>
      <email>robert.steffen@bausch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

